Published in Eye (Lond) on January 01, 1994
Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group. Br J Ophthalmol (1998) 1.91
Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrob Agents Chemother (2002) 1.28
Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers. Br J Ophthalmol (1998) 1.20
Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol (1998) 1.19
Flow cytometry for determination of the efficacy of contact lens disinfecting solutions against Acanthamoeba spp. Appl Environ Microbiol (2000) 1.11
Fluorescent oligonucleotide probes for clinical and environmental detection of Acanthamoeba and the T4 18S rRNA gene sequence type. J Clin Microbiol (1999) 1.09
Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea (2011) 1.02
Determination of amoebicidal activities of multipurpose contact lens solutions by using a most probable number enumeration technique. J Clin Microbiol (2003) 0.94
Medical management approach to infectious keratitis. Indian J Ophthalmol (2008) 0.93
Efficacy of commercial soft contact lens disinfectant solutions against Acanthamoeba. Jpn J Ophthalmol (2011) 0.88
Successful medical treatment of Acanthamoeba keratitis. Int Ophthalmol (1998) 0.86
Acanthamoeba-cytopathic protein induces apoptosis and proinflammatory cytokines in human corneal epithelial cells by cPLA2α activation. Invest Ophthalmol Vis Sci (2012) 0.85
Recent trends: Medical management of infectious keratitis. Oman J Ophthalmol (2015) 0.81
In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea. Antimicrob Agents Chemother (1998) 0.80
Acanthamoeba keratitis: first recorded case from a Palestinian patient with trachoma. Br J Ophthalmol (1996) 0.80
Double-biguanide therapy for resistant acanthamoeba keratitis. Case Rep Ophthalmol (2011) 0.80
Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba. Parasitol Res (2011) 0.80
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs. JAMA Ophthalmol (2013) 0.79
Cytotoxic effect of organic solvents and surfactant agents on Acanthamoeba castellanii cysts. Parasitol Res (2014) 0.78
Anti-Acanthamoeba efficacy in contact lens disinfecting systems. Br J Ophthalmol (2002) 0.76
Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol (1996) 0.76
The development of drugs against Acanthamoeba infections. Antimicrob Agents Chemother (2016) 0.75
Treatment of Acanthamoeba keratitis. Eye (Lond) (1994) 0.75
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis. Clin Ophthalmol (2010) 0.75
Confirmatory evidence from 18S rRNA gene analysis for in vivo development of propamidine resistance in a temporal series of Acanthamoeba ocular isolates from a patient. Antimicrob Agents Chemother (1998) 0.75
Medical interventions for acanthamoeba keratitis. Cochrane Database Syst Rev (2015) 0.75
Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba. Sci Rep (2017) 0.75
Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol (1983) 10.49
Opportunities for and challenges of computerisation. Lancet (1998) 4.39
Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol (2001) 3.98
Residual debris as a potential cause of postphacoemulsification endophthalmitis. Eye (Lond) (2003) 3.40
Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J (1975) 3.33
Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med (1999) 2.60
Pneumococcal immunisation and the healthy elderly. Lancet (1992) 2.58
A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (Lond) (1993) 2.57
Helping clinicians to find data and avoid delays. Lancet (1998) 2.57
Socioeconomic status and adolescent injuries. Soc Sci Med (1997) 2.48
Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis. Lancet (1995) 2.36
Significance of hyperintense vessels on FLAIR MRI in acute stroke. Neurology (2000) 2.27
Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol (1985) 2.18
A rationalised virological electron microscope specimen testing policy. PHLS North West Viral Gastroenteritis and Electron Microscopy Subcommittee. J Clin Pathol (1999) 2.09
Acanthamoeba griffini. Molecular characterization of a new corneal pathogen. Invest Ophthalmol Vis Sci (1996) 2.09
Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J Neurosci (1996) 2.01
Comparison of chlorine and chlorine dioxide disinfection for control of Legionella in a hospital potable water supply. J Hosp Infect (1996) 2.01
Aetiology and treatment of acute bacterial infection of the external eye. Br J Ophthalmol (1982) 1.94
Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry (1997) 1.94
Non-acanthamoeba amoebic keratitis. J Infect (1997) 1.92
18S ribosomal DNA typing and tracking of Acanthamoeba species isolates from corneal scrape specimens, contact lenses, lens cases, and home water supplies of Acanthamoeba keratitis patients in Hong Kong. J Clin Microbiol (2002) 1.74
Has the introduction of multi-purpose solutions contributed to a reduced incidence of Acanthamoeba keratitis in contact lens wearers? A review. Cont Lens Anterior Eye (1998) 1.69
Design of forms for clinical trials (1). Br Med J (1979) 1.64
Electric field-induced magnetization switching in epitaxial columnar nanostructures. Nano Lett (2005) 1.61
Design of forms for clinical trials (3). Br Med J (1979) 1.59
Ophthalmia neonatorum in the 1980s: incidence, aetiology and treatment. Br J Ophthalmol (1982) 1.59
Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology (1993) 1.58
Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. Pediatrics (1973) 1.57
A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr (2000) 1.56
Epidemiology of diarrhoea caused by enterotoxigenic Clostridium perfringens. J Med Microbiol (1985) 1.56
Quantitative tear lysozyme assay in units of activity per microlitre. Br J Ophthalmol (1976) 1.56
Acanthamoeba keratitis--resistance to medical therapy. Eye (Lond) (1990) 1.55
Lacrimal canaliculitis due to Arachnia (Actinomyces) propionica. Br J Ophthalmol (1981) 1.53
Design should help use of patients' data. Lancet (1998) 1.49
Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction. Br J Ophthalmol (1977) 1.49
Letter: Skin reactions to practolol. Br Med J (1974) 1.48
Salicylate inhibition of Acanthamoeba attachment to contact lenses: a model to reduce risk of infection. Ophthalmology (2000) 1.47
Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients. Clin Genet (1998) 1.47
The questionably dry eye. Br J Ophthalmol (1981) 1.46
The case against thiomersal. Lancet (1991) 1.45
Influenza in the family. N Engl J Med (2000) 1.42
Pathology of practolol-induced ocular toxicity. Br J Ophthalmol (1976) 1.39
Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med (2000) 1.36
Acanthamoeba and contact lens disinfection: should chlorine be discontinued? Br J Ophthalmol (1993) 1.36
Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res (1975) 1.35
Two HLA-D and DR alleles are associated with coeliac disease. Tissue Antigens (1979) 1.34
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J Infect Dis (2001) 1.34
Quality and quantity of survival in acute myeloid leukaemia. Lancet (1975) 1.31
Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci (1994) 1.28
Conjunctival autografting in the surgical management of pterygium. Eye (Lond) (1993) 1.25
Normal tear protein profiles and age-related changes. Br J Ophthalmol (1984) 1.23
Overwhelming odds: caregiving and the risk of institutionalization. J Gerontol (1990) 1.22
Group G streptococcal infections. J Infect (1987) 1.22
Non-culturable Legionella pneumophila associated with Acanthamoeba castellanii: detection of the bacterium using DNA amplification and hybridization. J Appl Bacteriol (1995) 1.21
Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers. Br J Ophthalmol (1998) 1.20
Population-based cohort study of microbial keratitis in Scotland: incidence and features. Cont Lens Anterior Eye (1999) 1.19
Granular corneal dystrophy. Visual results and pattern of recurrence after lamellar or penetrating keratoplasty. Ophthalmology (1994) 1.18
Is screening for bacteriuria in pregnancy worth while? Br Med J (Clin Res Ed) (1987) 1.18
The chemically injured eye. Trans Ophthalmol Soc U K (1982) 1.17
Maternal behavior during breast- and bottle-feeding. J Behav Med (1980) 1.17
An aberrant right hepatic artery from the right renal artery: anatomical vignette. Cardiovasc Intervent Radiol (1992) 1.16
Diagnosis and management of dry eyes. Trans Ophthalmol Soc U K (1971) 1.15
Waking at night: the effect of early feeding experience. Child Care Health Dev (1984) 1.15
Acute aortic stenosis of a porcine valve heterograft apparently caused by graft rejection: case report with discussion of immune mediated host response. Tex Heart Inst J (1982) 1.14
Amebic keratitis in a wearer of disposable contact lenses due to a mixed Vahlkampfia and Hartmannella infection. Ophthalmology (1996) 1.13
Sports related injuries in Scottish adolescents aged 11-15. Br J Sports Med (1998) 1.13
Conjunctival changes associated with inflammatory disease of the bowel. Trans Ophthalmol Soc U K (1980) 1.13
The vector homology problem in diagnostic nucleic acid hybridization of clinical specimens. J Clin Microbiol (1986) 1.13
Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Br J Cancer (2001) 1.13
Congenital hereditary corneal oedema of Maumenee: its clinical features, management, and pathology. Br J Ophthalmol (1987) 1.12
Measures of injury severity in childhood: a critical overview. Inj Prev (1998) 1.12
Subtyping intimin genes from enteropathogenic Escherichia coli associated with outbreaks and sporadic cases in the United Kingdom and Eire. Mol Cell Probes (2003) 1.11
Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain (2004) 1.11
Integrating cancer survivors' experiences into UK cancer registries: design and development of the ePOCS system (electronic Patient-reported Outcomes from Cancer Survivors). Br J Cancer (2011) 1.11
Longterm prognosis for corneal grafting in herpes simplex keratitis. Eye (Lond) (1988) 1.10
Streptococcal necrotising fasciitis: comparison between histological and clinical features. J Clin Pathol (1987) 1.10
Acanthamoeba keratitis in Scotland: risk factors for contact lens wearers. Cont Lens Anterior Eye (1999) 1.09
Fluorescent oligonucleotide probes for clinical and environmental detection of Acanthamoeba and the T4 18S rRNA gene sequence type. J Clin Microbiol (1999) 1.09
Microbial keratitis after penetrating keratoplasty. Eye (Lond) (1990) 1.08
Evidence that bilayer bending rigidity affects membrane protein folding. Biochemistry (1997) 1.08
Transmission disequilibrium analysis of HLA class II DRB1, DQA1, DQB1 and DPB1 polymorphisms in schizophrenia using family trios from a Han Chinese population. Schizophr Res (2001) 1.08
The human lacrimal gland. A histochemical and organ culture study of the secretory cells. Arch Ophthalmol (1972) 1.08
Bacteriotherapy for Clostridium difficile diarrhoea. Lancet (1989) 1.07
Characteristics of inapparent Aleutian disease virus infection in mink. Res Vet Sci (1978) 1.07
Incidence and distribution of injury among schoolchildren aged 11-15. Inj Prev (1996) 1.07
Acanthamoeba keratitis. BMJ (1994) 1.06
In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3. Eur J Neurosci (1994) 1.06
Data-driven assessment of the human ovarian reserve. Mol Hum Reprod (2011) 1.05
Necrotizing fasciitis with polymyositis. Br Med J (1975) 1.05
The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis. Ophthalmology (1993) 1.05
Botulinum toxin A induced protective ptosis. Eye (Lond) (1987) 1.04
The role of animal shelters in controlling pet overpopulation. J Am Vet Med Assoc (1991) 1.03
The effect of ageing and disease on tear constituents. Trans Ophthalmol Soc U K (1985) 1.02